COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)

By 2023, COVID-19 had caused 6.8 million deaths in the United States. COVID-19 presents more severely in leukemia compared to solid tumors (OR 1.6, p

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in oncology 2024-10, Vol.14, p.1446482
Hauptverfasser: Sivasubramanian, Barath Prashanth, Joshi, Shashvat, Ravikumar, Diviya Bharathi, Madhumithaa Jagannathan, Babu, Sonia, Sripathi, Shanthi Reddy, Javvaji, Avinash, Jain, Priyanshu, Kumar Shanmugam, Dinesh, Swami Kannan, Bharath Duraisamy, Tirupathi, Raghavendra, Dalal, Rutul
Format: Artikel
Sprache:eng
Schlagworte:
acute respiratory failure
AML
ARDS
COVID-19
myelodysplastic syndrome
Oncology
severe sepsis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:By 2023, COVID-19 had caused 6.8 million deaths in the United States. COVID-19 presents more severely in leukemia compared to solid tumors (OR 1.6, p
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2024.1446482